Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,944 | -12,501 | 63,087 | -41,027 | -26,282 |
| Depreciation Amortization | 83 | 43 | 183 | 139 | 94 |
| Income taxes - deferred | N/A | N/A | N/A | 233 | 233 |
| Accounts payable and accrued liabilities | -2,628 | -2,882 | -1,682 | -2,937 | -3,557 |
| Other Working Capital | -2,019 | -4,615 | 3,128 | 478 | -797 |
| Other Operating Activity | 7,155 | 5,352 | -106,627 | 11,285 | 9,301 |
| Operating Cash Flow | $-24,353 | $-14,603 | $-41,911 | $-31,829 | $-21,008 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 41 | 41 | 6,140 | 65 | 27 |
| Financing Cash Flow | $41 | $41 | $6,140 | $65 | $27 |
| Beginning Cash Position | 131,201 | 131,201 | 166,972 | 166,972 | 166,972 |
| End Cash Position | 106,889 | 116,639 | 131,201 | 135,208 | 145,991 |
| Net Cash Flow | $-24,312 | $-14,562 | $-35,771 | $-31,764 | $-20,981 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,353 | -14,603 | -41,911 | -31,829 | -21,008 |
| Free Cash Flow | -24,353 | -14,603 | -41,911 | -31,829 | -21,008 |